发明名称 Use of platelet activating factor acetylhydrolase as biomarker for anaphylaxis
摘要 A method for determining a patient's susceptibility to anaphylaxis comprises assaying the activity of platelet activating factor acetylhydrolase (PAF-AH) activity and comparing the measured activity to a reference value, wherein the level of PAF-AH activity inversely correlates with the susceptibility to anaphylaxis. The method further comprises determining the severity of anaphylaxis by correlating the degree of reduced PAF-AH activity to the reference value. The method further comprises measuring IgE concentration and comparing the measured concentration to a reference concentration. The invention further provides a method for diagnosing anaphylaxis in a patient comprising measuring the serum concentration of platelet activating factor (PAF) and comparing the measured concentration to a reference value, wherein the concentration of PAF correlates directly with severity of anaphylaxis. The invention also provides a kit for performing the required assay or assays.
申请公布号 US8257697(B2) 申请公布日期 2012.09.04
申请号 US20080262949 申请日期 2008.10.31
申请人 VADAS PETER;ALLERTECH LABORATORY INC. 发明人 VADAS PETER
分类号 A61K38/46;C12Q1/34 主分类号 A61K38/46
代理机构 代理人
主权项
地址